JD,

Nice post. I don't have an argument against it. However, as RH/biOasisi has indicated they are planning to take the oncology program to the clinic themselves. What about the rumored phase zero study that biOasis is in the process of preparing for (according to RH from an email a couple months ago)? Although that trial will likely be primarily pharmacokinetic in nature, do you anticipate its results having a positive impact on the perception of biOasis? I don't where or when this phase zero study will occur, and I also don't know if ClinicalTrials.gov even lists phase zero trial. But assuming it does occur soon and is completely quickly, then a follow up Phase 1 might be possible to complete in the next 18 months (depending on trial design and length of course). Would the results of a Phase 1 be considered beneficial (or conversely a threat depending on the results) if completed in the next 18 months?

BearDownAZ